Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
circ_0042103/TAF15/NER Axis Modulates DNA Damage in Pulpitis
2026-05-01
This study identifies the circ_0042103/TAF15/NER regulatory axis as a key driver of DNA damage and inflammation in human dental pulp stem cells during pulpitis. By elucidating how circular RNA impairs nucleotide excision repair, the research advances understanding of inflammatory dental disease pathogenesis and suggests new molecular targets for future therapeutic development.
-
Dabigatran: Advances in Oral Anticoagulation for Thromboembo
2026-05-01
This article reviews the landmark innovations and evidence supporting dabigatran, a direct thrombin inhibitor, for the prevention and treatment of thromboembolic disorders. The study delineates its pharmacological advantages over vitamin K antagonists, discusses safety, and highlights implications for translational cardiovascular research.
-
Selective Nuclear Export Inhibition Enhances Cas9 Editing Pr
2026-04-30
A recent study demonstrates that KPT330, a selective inhibitor of nuclear export, enhances the precision of CRISPR-Cas9 genome and base editing by regulating Cas9 mRNA export, thereby indirectly improving editing specificity. These findings expand the landscape of CRISPR-Cas modulation and suggest new strategies for minimizing off-target effects in genome editing applications.
-
Mianserin HCl: Protocols and Innovations in 5-HT2 Antagonist
2026-04-30
Leverage Mianserin HCl’s unique 5-HT2 receptor antagonist profile for advanced antidepressant and antipathogenic studies. This guide details optimal protocols, troubleshooting strategies, and clinical insights, helping researchers maximize experimental success with APExBIO’s rigorously validated compound.
-
Proteinase K: Broad-Spectrum Serine Protease in Genomic DNA
2026-04-29
Proteinase K’s robust enzymatic profile enables high-yield, high-integrity genomic DNA isolation even in the presence of nucleases and protein contaminants. Leveraging precise workflow parameters and troubleshooting strategies, APExBIO’s recombinant Proteinase K (K1037) streamlines DNA prep, proteomic analysis, and complex assay development across molecular biology.
-
Vitamin C as an Anticancer Agent: Advanced Workflows & HEV M
2026-04-29
Vitamin C (ascorbic acid) is emerging as a cornerstone in cancer and antiviral research, uniquely bridging organoid models and translational workflows. APExBIO’s high-purity Vitamin C empowers reproducible protocols for apoptosis induction and tumor cell inhibition, with direct application to advanced HEV infection platforms.
-
Bedaquiline (SKU B3492): Data-Driven Workflows for Tuberculo
2026-04-28
This article delivers scenario-driven, evidence-based guidance for deploying Bedaquiline (SKU B3492) in cell viability, proliferation, and cytotoxicity assays. Tailored for biomedical researchers and laboratory technicians, it addresses real-world workflow obstacles and demonstrates how APExBIO's Bedaquiline ensures reproducibility, sensitivity, and reliable data in tuberculosis and cancer metabolism research.
-
Arachidonic Acid Supplementation Accelerates Humoral Immunit
2026-04-28
This study demonstrates that oral arachidonic acid (ARA) supplementation significantly enhances the speed and magnitude of vaccine-induced neutralizing antibody responses in both mice and humans. By elucidating the metabolic pathways involved—particularly the role of ARA-derived prostaglandins in B cell activation—the findings offer a mechanistic basis for dietary modulation of humoral immunity and suggest new avenues for optimizing vaccine efficacy.
-
GDC-0941: Precision PI3K Inhibition for Advanced Oncology Mo
2026-04-27
Explore how GDC-0941, a potent PI3K inhibitor, enables precise dissection of PI3K/Akt signaling and overcomes key resistance mechanisms in cancer research. This in-depth article uniquely connects molecular action, protocol optimization, and translational implications for oncology workflows.
-
Synergistic Action of Hexetidine and Copper Against Oral Str
2026-04-27
The reference study demonstrated that combining hexetidine (NSC-17764) with copper ions produces a strong synergistic antibacterial effect against Streptococcus sobrinus and Streptococcus sanguis in vitro. This synergy significantly lowers minimum inhibitory concentrations, suggesting practical enhancements for oral infection research and biofilm inhibition assays.
-
Hybridization and Pluripotency Network Rewiring in Xenopus l
2026-04-26
This study reveals how interspecific hybridization in Xenopus laevis has fundamentally rewired the early embryonic pluripotency network, leading to asymmetric activation of homeologous genes across its two subgenomes. The research highlights the evolutionary pressures maintaining core gene expression dosage despite widespread regulatory divergence, providing new insights into vertebrate development and the application of transcriptional inhibitors in mechanistic studies.
-
Vemurafenib (PLX4032): Next-Gen Insights for Translational M
2026-04-25
This thought-leadership article bridges mechanistic insight and strategic guidance for translational researchers using Vemurafenib (PLX4032) in melanoma research. Integrating multi-omics findings, it contextualizes resistance mechanisms—especially ARID1A-dependent rewiring—while offering actionable experimental protocols and a forward-looking perspective. By referencing both foundational and cutting-edge literature, as well as APExBIO’s rigorous reagent standards, it transcends standard product pages to arm cancer biologists with a systems-level, evidence-backed playbook.
-
2X HyperFusion High-Fidelity Master Mix in Precision Cloning
2026-04-24
2X HyperFusion™ High-Fidelity Master Mix delivers ultra-low error rates and robust blunt-end PCR products, making it a standout solution for cloning and gene-editing workflows. With its advanced HyperFusion high-fidelity DNA polymerase, it empowers researchers to achieve reproducibility and accuracy in high-stakes molecular biology assays.
-
Brain-to-Spinal Circuits Regulate Mechanical Allodynia Later
2026-04-24
Huo et al. (2023) reveal a contralateral brain-to-spinal circuit involving Oprm1+ and Pdyn+ neurons that governs the laterality and duration of mechanical allodynia in mice. These insights refine our understanding of pain modulation and highlight the role of spinal κ-opioid receptors in gating hypersensitivity.
-
Topotecan HCl: DNA Damage, Repair, and Precision Oncology
2026-04-23
Explore how Topotecan HCl, a potent topoisomerase 1 inhibitor, advances our understanding of DNA damage, repair, and precision antitumor strategies. Gain unique insight into DNA repair vulnerabilities and practical assay guidance for cutting-edge oncology research.